Why the study?
Recent biochemical and structural studies have begun to close knowledge gaps regarding how cardiovirus 2A protein functions as an RNA-binding protein in diverse translation-related processes.
This review highlights the structural and biochemical mechanisms by which the cardiovirus 2A protein regulates viral and host translation, potentially informing broader RNA-mediated gene expression strategies.
May inform antiviral strategies against cardioviruses; leaves open clinical translation to myocarditis or host translation therapies.
Cardioviruses are single-stranded RNA viruses of the family Picornaviridae. In addition to being the first example of internal ribosome entry site (IRES) utilization, cardioviruses also employ a series of alternative translation strategies, such as Stop-Go translation and programmed ribosome frameshifting. Here, we focus on cardiovirus 2A protein, which is not only a primary virulence factor, but also exerts crucial regulatory functions during translation, including activation of viral ribosome frameshifting and inhibition of host cap-dependent translation. Only recently, biochemical and structural studies have allowed us to close the gaps in our knowledge of how cardiovirus 2A is able to act in diverse translation-related processes as a novel RNA-binding protein. This review will summarize these findings, which ultimately may lead to the discovery of other RNA-mediated gene expression strategies across a broad range of RNA viruses.
No takes yet. Share an insight, caveat, or question.
Caliskan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: